Germany-based Deutsche Bank AG said on Wednesday that it had infused 51.13 billion rupees ($607.50 million) into its Indian ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on AstraZeneca (AZN – Research Report), with a price target of £105.00. The company’s shares opened ...

Deutsche Bank AG made its largest capital allocation to India in recent years by increasing its regulatory capital 33% to 300 ...

Deutsche Bank announced that more than a hundred posts will be axed among its senior private wealth and retail bankers in a continuing programme aimed at driving down costs at the German bank.

Germany-based Deutsche Bank has pumped Rs51.13bn (around $607m) into its India operations to support growth through digital transformation. The infusion, alongside retained earnings and other ...

(MENAFN- IANS) New Delhi, Nov 7 (IANS) German lender Deutsche bank has announced the infusion of an additional Rs 5,113 crore to bolster its India operations. This is the largest capital ...

Deutsche Bank has infused ₹5,113 crore into its India branch operations to fund its growth plans in the country, according to a statement. “The above (fresh capital), along with retained ...

But it's not yet time for investors to relax, Deutsche Bank wrote on Monday. Though inflation now hovers close to the Federal Reserve's 2% target rate, it's not yet time to declare victory ...

These funds, along with retained earnings and other statutory components, increase the capital at Deutsche Bank AG India branches to nearly Rs 30,000 crore, a 33% increase over 2023 levels ...